- Home
- PRTG
PRTG
Portage Biotech Inc.
as 07-26-2024 3:35pm EST
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
| Founded: | 1973 | Country: | VG |
| Employees: | N/A | City: | N/A |
| Market Cap: | 5.2M | IPO Year: | N/A |
| Target Price: | $11.00 | AVG Volume (30 days): | 2.0M |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.13 - $3.25 | Next Earning Date: | 08-28-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Portage Biotech Inc. News
PRTG Breaking Stock News: Dive into PRTG Ticker-Specific Updates for Smart Investing
MT Newswires
22 days ago
Converge Technology Solutions Rating, Price Target Left Unchanged by National Bank Following Deconsolidation of Portage CyberTech
GlobeNewswire
3 months ago
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
GlobeNewswire
4 months ago
Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
Zacks Small Cap Research
5 months ago
PRTG: Extending the Runway
GlobeNewswire
5 months ago
Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update
GlobeNewswire
6 months ago
Northann Corp.’s New 3-D Printing Ecosystem Products Receive “Best of” Innovation Awards at TISE2024
NewMediaWire
6 months ago
Mullen Super-Crossover Five RS Spotlighted in AutoCar Article
Simply Wall St.
6 months ago
We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely
Compare PRTG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRTG Portage Biotech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.